Australia Markets closed

Why BWX, Medibank, SEEK, & Westpac shares are sinking lower today

James Mickleboro
share price down

The S&P/ASX 200 index is on course to record another disappointing decline. In afternoon trade the benchmark index is down 0.7% to 6,675.2 points.

Four shares that are falling more than most today are listed below. Here’s why they are sinking lower:

The BWX Ltd (ASX: BWX) share price has tumbled 5.5% to $4.37 on the day of its annual general meeting. I suspect that some investors were hoping the personal care products company would upgrade its guidance at the event. However, management has reiterated its expectation for revenue growth of 20% to 25% and EBITDA growth of 25% to 35% in FY 2020.

The Medibank Private Ltd (ASX: MPL) share price is down 2% to $3.11. This decline could be down to a broker note out of Goldman Sachs According to the note, its analysts have retained their sell rating and $2.68 price target on its shares. This follows the release of APRA private health insurance industry data for the September quarter. That data shows that policyholder growth remains soft, while claims growth is picking up. Goldman believes this is putting pressure on Medibank’s margins.

The SEEK Limited (ASX: SEK) share price has fallen 3% to $22.05. This decline also appears to have been driven by a broker note. According to a note out of Morgans, its analysts have downgraded SEEK to a hold rating with a $21.82 price target. Morgans made the move on valuation grounds and due to concerns over its Zhaopin business. It believes the trade war is impacting the China-based job listings business.

The Westpac Banking Corp (ASX: WBC) share price is under pressure again and down a further 2% to $25.15. The banking giant’s shares have been sold off this week after AUSTRAC launched civil proceedings against it. This is in relation to alleged contraventions of its obligations under the Anti-Money Laundering and Counter-Terrorism Financing Act. Westpac’s shares are now trading lower than the price it raised $2 billion at from institutional investors earlier this month.

The post Why BWX, Medibank, SEEK, & Westpac shares are sinking lower today appeared first on Motley Fool Australia.

The Best Blue Chip Shares for 2020 – NOW AVAILABLE!

You’re invited! For a limited time, The Motley Fool Australia is giving away an urgent new investment report detailing our 3 TOP BLUE CHIP SHARES to own in 2019.

So if you like trustworthy, stable, high-performing companies that pay fat fully franked dividends – we’ve got you covered!

Stock #1 is a beloved old Australian company turning its attention to high-margin businesses... and rapidly returning cash to shareholders with its hefty dividend...

While Stock #2 is an online powerhouse that’s rapidly gaining market share all around the globe... poised for years (or even decades) of tremendous growth...

Even better, Stock #3 offers a whopping 6.5% grossed-up dividend! Which beats the rates on term deposits right out of the water – and offers the potential for capital gains, too.

You can discover all three shares inside our new report right now. To scoop up your FREE copy, simply click the link below right now. But you will want to hurry – this free report is available for a LIMITED TIME ONLY!


More reading

Motley Fool contributor James Mickleboro owns shares of SEEK Limited and Westpac Banking. The Motley Fool Australia owns shares of and has recommended BWX Limited. The Motley Fool Australia has recommended SEEK Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2019